Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis.

Yu-Wen ChangMeng-Yun TsaiYu-Ping ChangChien-Chang LiaoYu-Ting LinChien-Hao LaiMeng-Chih LinKuo-Tung Huang

Published in: Drugs - real world outcomes (2024)

Aggressive management of ADRs may enhance patient tolerance to nintedanib, potentially prolonging treatment duration and improving outcomes in chronic fibrotic ILD.

Keyphrases

interstitial lung disease
systemic sclerosis
idiopathic pulmonary fibrosis
adverse drug
rheumatoid arthritis
drug induced
case report
electronic health record
metabolic syndrome
emergency department
adipose tissue
type diabetes
skeletal muscle
glycemic control